NationalNEWSFLASH: Govt Expert Panel Recommends Regular Market Approval For Covishield And CovaxinBY Outlook Web Desk
miscellaneousMix & Match Of Covaxin, Covishield Elicits 4 Times Antibody Response, Says StudyBY Outlook Web Desk
miscellaneousCentre should allow vaccination of children in 12-15 age group: Maha health ministerBY Outlook Web Desk
miscellaneousSecond COVID-19 Vaccine Dose Of 18 Lakh People Overdue In West BengalBY Outlook Web Desk
NationalCovishield Gets Poland's Recognition, Exemption From Quarantine Granted For Those Who Take ItBY Outlook Web Desk
National100 Crore Shots: How India Achieved Covid-19 Vaccination Milestone In 280 DaysBY Outlook Web Desk
Making A DifferenceCountries On Vaccine Eligibility List Under 'Constant Review', Say UK Govt Sources After India’s Reciprocal ActionBY Outlook Web Desk
NationalCovishield Gets Australian Medicine Regulator's Approval For Incoming TravellersBY Outlook Web Desk
NationalCentre To Receive 20 Crores Of Covishield Doses From Serum Institute In SeptemberBY Outlook Web Desk
NationalOver 3.86 Crore People Yet To Get Complete Vaccination Within Stipulated Time: GovtBY Outlook Web Desk
NationalCentre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector QuotaBY Outlook Web Bureau
NationalMixing Covaxin and Covishield: India's Drug Authority Gives Nod To Study, TrialsBY Outlook Web Desk
NationalCombination Of Covishield, Covaxin Better Than 2 Doses Of Same Vaccine: ICMR StudyBY Outlook Web Bureau
NationalRevised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health MinisterBY Outlook Web Desk
NationalCovid-19: Delhi Govt Reserves 40% Covaxin Stock And 20% Covishield Jabs For 1st ShotBY Outlook Web Bureau
NationalFather-Daughter Duo Who Risked Life For Vaccine Trial Begs For Jabs For KinBY Jeevan Prakash Sharma
Making A DifferenceNot Received Marketing Authorisation Application For Covishield: EU Medical BodyBY Outlook Web Bureau
NationalPregnant Women Now Eligible For Covid Vaccine, Can Register On CoWin Or Walk-InBY Outlook Web Bureau
Making A DifferenceAfter Hiccups, Nine European Nations Accept India’s Covishield For Travel: SourcesBY Outlook Web Bureau
